STAT5A and pachyonychia congenita: One of the key results presented in the work shows that a specific small-molecule Stat5 inhibitor IST5-002, which inhibits both phosphorylation and dimerization of Stat5 (36, 39), suppressed AR mRNA and protein levels in preclinical PC models and patient-derived PC samples with high potency.